Xiamen SJ Works Import & Export Co.,Ltd – Trademark Portfolio

Entity Type: 99

Xiamen SJ Works Import & Export Co.,Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SJ WORKS FIRST AID ESSENTIALS. The owner is based in Xiamen, Fujian.

Unit10, 7F Building Haixiwenchuang

No.16 Yiai Road Siming District

Xiamen, Fujian 361000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Xiamen SJ Works Import & Export Co.,Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Xiamen SJ Works Import & Export Co.,Ltd have?

Xiamen SJ Works Import & Export Co.,Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xiamen SJ Works Import & Export Co.,Ltd file in?

Xiamen SJ Works Import & Export Co.,Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Xiamen SJ Works Import & Export Co.,Ltd's most well-known trademarks?

Xiamen SJ Works Import & Export Co.,Ltd's registered trademark portfolio includes well-known marks such as SJ WORKS FIRST AID ESSENTIALS. These are among 1 currently registered trademark in the portfolio.

What is Xiamen SJ Works Import & Export Co.,Ltd's trademark registration success rate?

Xiamen SJ Works Import & Export Co.,Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.